Menu

quarta-feira, 12 de abril de 2017

The FDA just approved a new drug to treat a serious side effect to certain medications

http://www.businessinsider.com/r-update-1-neurocrine-biosciences-gets-fdas-ok-for-movement-disorder-drug-2017-4

Remédio pra discinesia tardia.

Nenhum comentário:

Postar um comentário